7 completed, 3 unknown, 2 recruiting, 1 not yet recruiting. 4 Phase 3, 2 Not applicable, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Unknown 2 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Idiopathic Nephrotic Syndrome: new trials by email Literature Review of Idiopathic Nephrotic Syndrome trials Research Report on Idiopathic Nephrotic Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study Conventional 24-week glucocorticoid regimen, short-term course (12 week) glucocorticoid regimen - Idiopathic Nephrotic Syndrome | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 224 | 2026-01-01 | 2025-09-03 |
| A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood. Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome, - Idiopathic Nephrotic Syndrome | Recruiting | University Hospital, Limoges | 1180 | 2020-03-13 | 2026-03-13 | |
| Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome Transcutaneous Auricular Vagus Nerve (taVNS) stimulation - Idiopathic Nephrotic Syndrome, Frequently Relapsing Nephrotic Syndrome | Not applicable | Completed | Northwell Health | 7 | 2019-12-01 | 2022-09-28 |
| UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort) Standard of Care, UrApp - Idiopathic Nephrotic Syndrome | Not applicable | Completed | Emory University | 58 | 2019-09-17 | 2025-11-06 |
| Reduce Immunosuppression With Atmp in NS ChildrEn Cord-blood mesenchymal stromal cells - Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome | Phase 2 | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 20 | 2018-11-02 | 2023-09-28 |
| Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Rituximab, Prednisone - Idiopathic Nephrotic Syndrome, Minimal Change Disease | Phase 3 | Unknown | Radboud University Medical Center | 40 | 2018-08-22 | 2018-08-27 |
| The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) Biosampling - Glomerulosclerosis, Focal Segmental, Minimal Change Disease | Recruiting | Prof. Dr. Paul Brinkkoetter | 500 | 2018-04-01 | 2025-09-17 | |
| Valproic Acid for Idiopathic Nephrotic Syndrome Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2 / Phase 3 | Unknown | Universitair Ziekenhuis Brussel | 15 | 2016-10-01 | 2017-06-20 |
| Rituximab for Idiopathic Nephrotic Syndrome Rituximab - Idiopathic Nephrotic Syndrome | Phase 3 | Completed | Istituto Giannina Gaslini | 30 | 2013-07-01 | 2023-01-04 |
| Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome DNA chip dedicated to the pharmacogenetic of steroids - Idiopathic Nephrotic Syndrome | Completed | Assistance Publique - Hôpitaux de Paris | 351 | 2012-09-01 | 2017-03-27 | |
| Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children Cyclophosphamide, Mycophenolate mofetil - Idiopathic Nephrotic Syndrome | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 70 | 2010-09-01 | 2015-03-26 |
| Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome 7-valent pneumococcal conjugate vaccine - Idiopathic Nephrotic Syndrome | Phase 4 | Unknown | National and Kapodistrian University of Athens | 50 | 2009-01-01 | 2011-05-02 |
| Kidney Disease Biomarkers Kidney Disease, Glomerular Disease | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 25 | 2005-11-10 | 2019-12-17 |
Nephrosis, Lipoid (13) · Nephrotic Syndrome (5) · Glomerulosclerosis, Focal Segmental (4) · Proteinuria (4) · Diabetic Nephropathies (1) · Herpes Simplex (1) · Kidney Diseases (1) · Macular dystrophy, corneal type 1 (1)
Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Male Urogenital Diseases (13) · Nephrosis (13) · Urogenital Diseases (13) · Urologic Diseases (13) · Kidney Diseases (12) · Glomerulonephritis (4) · Nephritis (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Urination Disorders (4) · Urological Manifestations (4) · DNA Virus Infections (1) · Diabetes Complications (1)
Rituximab (2) · Congresses as Topic (1) · Cyclophosphamide (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Mycophenolic Acid (1) · Prednisolone (1) · Prednisone (1) · Standard of Care (1) · Valproic Acid (1)
Assistance Publique - Hôpitaux de Paris (2) · Emory University (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Istituto Giannina Gaslini (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · National and Kapodistrian University of Athens (1) · Northwell Health (1) · Prof. Dr. Paul Brinkkoetter (1) · Radboud University Medical Center (1) · Universitair Ziekenhuis Brussel (1) · University Hospital, Limoges (1)
France (3) · United States (3) · Italy (2) · Belgium (1) · China (1) · Germany (1) · Greece (1) · Netherlands (1) · Reunion (1)
Chia-shi Wang, MD, MS (1) · Christina Liakou, MD (1) · Christine Sethna, MD (1) · Gian Marco Ghiggeri, MD (1) · Jack F Wetzels, MD, PhD (1) · Jeffrey B Kopp, M.D. (1) · Jeroen K Deegens, MD,PhD (1) · Maria Theodoridou, Dr (1) · Paul T Brinkkoetter, MD (1) · Peter Janssens, MD (1) · Vana Spoulou, Dr (1) · Vincent Guigonis, MD (1)
PMID 39513526, PMID 32272901, PMID 35078538, PMID 35224732, PMID 35230699, PMID 37117201, PMID 40032676
2018 (1), K23DK118189 (1)